Peptide content vs chromatographic purity: why a 99% COA does not tell you how much peptide is in the vial

Two numbers on a certificate of analysis are routinely conflated: purity and peptide content. They are not the same measurement, they are not determined by the same technique, and they answer different questions. Chromatographic purity describes the composition of the peptide-related material in the sample — what fraction of the detected species is the target sequence rather than a related impurity. Peptide content describes the composition of the vial by mass — what fraction of the lyophilized powder is actually peptide rather than counterion, water, or residual salts. A preparation can legitimately report 99% purity and still be less than 80% peptide by weight.

This distinction is not a technicality. It determines how much peptide a given vial actually contains, and it is the single most common source of discrepancy between what a COA states and what a quantitative assay downstream reports. The two values are frequently reported side by side without explanation, and in many cases peptide content is not reported at all.

What chromatographic purity actually measures

Purity on a peptide COA is almost always determined by reversed-phase high-performance liquid chromatography (RP-HPLC) with UV detection, typically at 214 nm where the peptide bond absorbs, sometimes at 220 or 280 nm. The sample is dissolved, injected onto a C18 column, and eluted with a gradient of increasing organic solvent. Species separate by hydrophobicity. The detector records absorbance over time, producing a chromatogram of peaks.

Purity is then calculated as area normalization: the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage. A 99% purity figure means the main peak accounts for 99% of the total integrated UV-absorbing area.

The important consequence follows directly from the method. Area normalization is blind to anything that does not produce a peak in the chromatogram. Water does not absorb at 214 nm. Inorganic salts elute in the void volume and are typically excluded from integration. Trifluoroacetate has weak absorbance in that region and is generally not counted as an impurity peak. None of these materials appear in the purity calculation, yet all of them contribute mass to the vial.

Purity is therefore a statement about the peptide-related fraction of the sample. It says the synthesis and purification produced a clean target sequence relative to deletion sequences, truncations, oxidized forms, and other synthesis byproducts. It says nothing about how much of the powder is peptide.

What peptide content measures, and how it is determined

Peptide content — sometimes labeled peptide assay, net peptide content, or simply content — is the mass fraction of the lyophilate that is peptide. If a vial contains 10 mg of powder at 80% peptide content, it holds 8 mg of peptide and 2 mg of everything else.

Several techniques are used to determine it, with meaningfully different characteristics.

Amino acid analysis (AAA) is the reference method. The peptide is completely hydrolyzed, typically in 6 M hydrochloric acid at elevated temperature under vacuum, breaking every peptide bond and releasing free amino acids. Those amino acids are then derivatized and quantified chromatographically against calibrated standards. Because the amino acid composition of the target sequence is known, the measured quantities can be back-calculated to the mass of peptide in the sample. AAA is accurate and largely independent of the reference standard problem that affects other methods, but it is slow, destructive, and requires care — tryptophan is degraded by acid hydrolysis, cysteine requires derivatization to survive, and serine and threonine are partially destroyed and need time-course correction.

Nitrogen determination by Kjeldahl or combustion analysis measures total nitrogen and converts to peptide mass using the theoretical nitrogen content of the sequence. It is fast, but it counts nitrogen from any source, so nitrogen-containing impurities inflate the result.

Quantitative UV spectroscopy at 280 nm uses the calculated extinction coefficient from tryptophan, tyrosine, and cystine content. It is fast and non-destructive but only applies to sequences containing those residues, and is sensitive to interfering absorbers.

Quantitative NMR (qNMR) with an internal standard has become more common. It is accurate and non-destructive, but requires sufficient sample and a soluble, non-overlapping standard.

Where a COA reports peptide content without naming the method, the value is difficult to interpret. AAA and qNMR are the values that carry the most weight.

Where the missing mass goes

For a typical lyophilized synthetic peptide, the non-peptide mass falls into three categories.

Counterion. Synthetic peptides carry charged side chains — the basic residues lysine, arginine, and histidine, and the free N-terminal amine. Those charges are balanced by counterions acquired during purification. Because RP-HPLC of peptides is conventionally run with trifluoroacetic acid as an ion-pairing agent, the peptide typically emerges as a TFA salt. Trifluoroacetate has a formula weight of 113 g/mol, and a peptide with several basic residues can carry several equivalents. For a small, highly basic peptide, TFA can account for 10–20% of the total mass. Acetate salts, produced by salt exchange, are lighter at 59 g/mol and correspondingly contribute less mass. Hydrochloride is lighter still.

Water. Lyophilized peptides are hygroscopic. Residual moisture after lyophilization is commonly in the range of a few percent, and additional water is absorbed rapidly on exposure to ambient humidity — which is the practical reason vials are equilibrated to room temperature before opening. Water content is measured by Karl Fischer titration or thermogravimetric analysis when it is reported at all.

Residual salts and solvents. Buffer salts carried through from purification, and residual acetonitrile or other organic solvents from the mobile phase, contribute smaller amounts. Residual solvents are separately regulated in pharmaceutical contexts and typically assessed by gas chromatography.

Together these routinely account for 10–25% of the mass of a lyophilate that is, by HPLC, 99% pure.

Why the counterion question matters analytically

The counterion is not merely a mass accounting issue. Two considerations follow from it.

First, quantitative comparability. If two lots of the same peptide are prepared as different salt forms, equal masses of powder contain different quantities of peptide. Studies indicate this is a recurring source of unexplained variability between lots and between suppliers in quantitative work. The correction is straightforward when peptide content is reported and ignored when it is not.

Second, TFA itself has been characterized as biologically active in some assay systems at concentrations that can be reached when a TFA-salt peptide is dissolved at high concentration. Reported effects in cell-based systems include cytotoxicity and interference with certain functional readouts. This is well documented in the peptide chemistry literature and is the reason salt exchange to acetate or hydrochloride is standard practice for peptides destined for cell culture work. For purely analytical characterization the salt form is usually irrelevant; for functional in vitro work it can be a confounder.

Reading the two numbers together

A COA that reports both values allows a straightforward calculation. A 10 mg vial at 99.1% HPLC purity and 82% peptide content contains approximately 8.2 mg of peptide, of which approximately 99.1% is the target sequence — roughly 8.1 mg of the intended molecule. Reconstitution math based on the labeled 10 mg overstates the peptide concentration by more than 20%.

A COA that reports purity alone leaves that calculation impossible. In that case the labeled mass is best read as the mass of powder in the vial, not the mass of peptide, and quantitative work that depends on knowing concentration precisely requires either an independent content determination or a supplier who will provide one. Some suppliers fill vials on a peptide-content-corrected basis, so that a vial labeled 10 mg contains 10 mg of net peptide and a correspondingly larger mass of powder. That practice is not universal and is worth confirming rather than assuming, because the two conventions differ by exactly the margin in question.

The general pattern worth internalizing is that purity and content are orthogonal. High purity with low content describes a clean synthesis that was never salt-exchanged or thoroughly dried. Lower purity with high content describes a well-desalted preparation with more synthesis-related impurities. Neither number substitutes for the other, and a COA reporting only one has answered only half of the question.